Literature DB >> 27702559

The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well.

David R Milich1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27702559     DOI： 10.1053/j.gastro.2016.09.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

1.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

Review 2.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

3.  Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen.

Authors:  Hongyu Huang; Mingzhe Ning; Jingli Liu; Jie Chen; Jing Feng; Yimin Dai; Yali Hu; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

Review 4.  Perspectives on current controversial issues in the management of chronic HBV infection.

Authors:  Yun-Fan Liaw
Journal:  J Gastroenterol       Date:  2022-09-02       Impact factor: 6.772

5.  Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

Authors:  Sreya Biswas; Lauren N Rust; Jochen M Wettengel; Sofiya Yusova; Miranda Fischer; Julien N Carson; Josie Johnson; Lei Wei; Trason Thode; Mohan R Kaadige; Sunil Sharma; Majd Agbaria; Benjamin N Bimber; Thomas Tu; Ulrike Protzer; Alexander Ploss; Jeremy V Smedley; Gershon Golomb; Jonah B Sacha; Benjamin J Burwitz
Journal:  Nat Commun       Date:  2022-05-30       Impact factor: 17.694

6.  Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.

Authors:  Keigo Kawashima; Masanori Isogawa; Susumu Hamada-Tsutsumi; Ian Baudi; Satoru Saito; Atsushi Nakajima; Yasuhito Tanaka
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 7.  Tolerance and immunity to pathogens in early life: insights from HBV infection.

Authors:  Michelle Hong; Antonio Bertoletti
Journal:  Semin Immunopathol       Date:  2017-07-06       Impact factor: 9.623

Review 8.  Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks.

Authors:  Patrick T F Kennedy; Samuel Litwin; Grace E Dolman; Antonio Bertoletti; William S Mason
Journal:  Viruses       Date:  2017-04-29       Impact factor: 5.048

Review 9.  HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Authors:  Thomas Tu; Magdalena A Budzinska; Nicholas A Shackel; Stephan Urban
Journal:  Viruses       Date:  2017-04-10       Impact factor: 5.048

10.  Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Authors:  D C Whitacre; C J Peters; C Sureau; K Nio; F Li; L Su; J E Jones; M Isogawa; M Sallberg; L Frelin; D L Peterson; D R Milich
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.